✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Vimta Labs Ltd.

VIMTALABS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,458 Cr.
P/E
48.97

Vimta Labs Ltd.

  • Vimta Labs
  • Krsnaa Diagnostics
  • Thyrocare Tech.
  • TJI Pharma

FAQs on Vimta Labs Ltd. Shareprice

Vimta Labs has given better returns compared to its competitors.
Vimta Labs has grown at ~63.87% over the last 3yrs while peers have grown at a median rate of 15.06%

Yes, Vimta Labs is expensive.
Latest PE of Vimta Labs is 48.97, while 3 year average PE is 25.36.
Also latest EV/EBITDA of Vimta Labs is 26.47 while 3yr average is 12.4.

View FAQ's On Business

Growth Table

  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Balance Sheet

  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Cash Flow

  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Quarterly Results

  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Thyrocare Tech.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vimta Labs Ltd. Financials

Balance sheet of Vimta Labs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Vimta Labs is decreasing.
Latest net debt of Vimta Labs is -₹57.08 Crs as of Mar-25.
This is less than Mar-24 when it was -₹32.14 Crs.

Yes, profit is increasing.
The profit of Vimta Labs is ₹72.82 Crs for TTM, ₹67.34 Crs for Mar 2025 and ₹41.01 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vimta Labs latest dividend payout ratio is 6.66% and 3yr average dividend payout ratio is 8.37%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech